Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400088352Phase 4Not yet recruiting
Phase 4, open-label trial of norepinephrine and phenylephrine in hypotension (3 arms), sponsored by Subei People's Hospital. Primary endpoint: Cardiac index. Planned start Aug 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400088352.